News | Ventricular Assist Devices (VAD) | October 05, 2015

Catheter-Based Heart Failure Pump Wins Innovative Technology Design Competition

Six-cm device features powerful micro-pump to rest and heal the heart without surgery
 

Procyrion, Aortix device, grand prize, Create the Future Design Contest

October 5, 2015 — Procyrion Inc. of Houston has been awarded the grand prize of $20,000 in the 2015 "Create the Future" Design Contest for the first catheter-deployed heart pump intended for long-term treatment of chronic heart failure. The Aortix device — thinner than a No. 2 pencil and only 6 cm long — features a powerful micro-pump designed to rest and heal the heart without surgery and with minimal risk.

Aortix was among the record 1,159 new product ideas submitted in the 13th annual design contest, which was established in 2002 to recognize and reward engineering innovations that benefit humanity, the environment and the economy. This year's design contest was co-sponsored by COMSOL and Mouser Electronics. Analog Devices and Intel were supporting sponsors.

In addition to the grand prize of $20,000, first-place winners were named in seven categories in various industries. In the medical field Smart X-ray Source won for combining flat panel X-ray detector technology with classic X-ray physics to provide portable, inexpensive computed tomography (CT) systems using open software sources to underserved populations around the world.

Finalists were selected by senior editors at Tech Briefs Media Group and judged by an independent panel of design engineers. Visitors to the contest website could vote on entries, with the 10 most popular designs awarded an Ollie robotic gaming device provided by Sphero.

For more information: www.createthefuturecontest.com


Related Content

News | Heart Failure

April 30, 2024 — A multicenter study led by Vanderbilt University Medical Center (VUMC) and Lipscomb University College ...

Home April 30, 2024
Home
News | Heart Failure

April 16, 2024 — Each year more than 500,000 Americans undergo percutaneous coronary intervention, or PCI, a minimally ...

Home April 16, 2024
Home
News | Heart Failure

April 12, 2024 — University of Virginia School of Medicine researchers have discovered a gene on the Y chromosome that ...

Home April 12, 2024
Home
News | Heart Failure

April 2, 2024 — People who use e-cigarettes are significantly more likely to develop heart failure compared with those ...

Home April 02, 2024
Home
News | Heart Failure

March 29, 2024 — V-Wave announced it will present late-breaking data from its RELIEVE-HF pivotal trial at the American ...

Home March 29, 2024
Home
News | Heart Failure

March 25, 2024 — A team of engineers led by the University of Massachusetts Amherst and including colleagues from the ...

Home March 25, 2024
Home
News | Heart Failure

March 15, 2024 — BioCardia, Inc. , a biotechnology company focused on advancing late-stage cell therapy interventions ...

Home March 15, 2024
Home
News | Heart Failure

March 15, 2024 — BioCardia, Inc., a biotechnology company focused on advancing late-stage cell therapy interventions for ...

Home March 15, 2024
Home
News | Heart Failure

March 13, 2024 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of ...

Home March 13, 2024
Home
News | Heart Failure

March 8, 2024 — The Texas Heart Institute, Georgia Institute of Technology (Georgia Tech), North Carolina State ...

Home March 08, 2024
Home
Subscribe Now